Yingjia Ni - Publications
Affiliations: | 2012-2018 | Biological Sciences | University of Notre Dame, Notre Dame, IN, United States |
Year | Citation | Score | |||
---|---|---|---|---|---|
2022 | Li D, Wang C, Ni Y, Liu Y, Wang W, Zhang S, Chang HC, Senapati S. Development of a Multi-target Protein Biomarker Assay for Circulating Tumor Cells. Methods in Molecular Biology (Clifton, N.J.). 2394: 3-18. PMID 35094318 DOI: 10.1007/978-1-0716-1811-0_1 | 0.563 | |||
2020 | Zhang W, Zhang K, Yao Y, Liu Y, Ni Y, Liao C, Tu Z, Qiu Y, Wang D, Chen D, Qiang L, Li Z, Jiang S. Dual nicotinamide phosphoribosyltransferase and epidermal growth factor receptor inhibitors for the treatment of cancer. European Journal of Medicinal Chemistry. 113022. PMID 33239261 DOI: 10.1016/j.ejmech.2020.113022 | 0.341 | |||
2020 | Zhang Q, Yang Z, Ni Y, Bai H, Han Q, Yi Z, Yi X, Agbana YL, Kuang Y, Zhu Y. NF-κB and pSTAT3 synergistically drive G6PD overexpression and facilitate sensitivity to G6PD inhibition in ccRCC. Cancer Cell International. 20: 483. PMID 33041664 DOI: 10.1186/s12935-020-01576-2 | 0.305 | |||
2017 | Schmidt KR, Ni Y, Zhang S. Abstract LB-321: Cytoplasmic DEDD promotes G1- to S-phase cell cycle transition Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Lb-321 | 0.614 | |||
2015 | Ni Y, Zhang S. Erbb4 Signaling: an overlooked backup system? Cell Cycle (Georgetown, Tex.). 14: 1623. PMID 25945734 DOI: 10.1080/15384101.2015.1032653 | 0.695 | |||
Show low-probability matches. |